Cargando…

The association of eicosanoids and eicosanoid-related metabolites with pulmonary hypertension

BACKGROUND: Eicosanoids are bioactive lipids that regulate systemic inflammation and exert vasoactive effects. Specific eicosanoid metabolites have previously been associated with pulmonary hypertension (PH), yet their role remains incompletely understood. METHODS: We studied 482 participants with c...

Descripción completa

Detalles Bibliográficos
Autores principales: McNeill, Jenna N., Roshandelpoor, Athar, Alotaibi, Mona, Choudhary, Arrush, Jain, Mohit, Cheng, Susan, Zarbafian, Shahrooz, Lau, Emily S., Lewis, Gregory D., Ho, Jennifer E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586234/
https://www.ncbi.nlm.nih.gov/pubmed/37857430
http://dx.doi.org/10.1183/13993003.00561-2023
_version_ 1785123114813751296
author McNeill, Jenna N.
Roshandelpoor, Athar
Alotaibi, Mona
Choudhary, Arrush
Jain, Mohit
Cheng, Susan
Zarbafian, Shahrooz
Lau, Emily S.
Lewis, Gregory D.
Ho, Jennifer E.
author_facet McNeill, Jenna N.
Roshandelpoor, Athar
Alotaibi, Mona
Choudhary, Arrush
Jain, Mohit
Cheng, Susan
Zarbafian, Shahrooz
Lau, Emily S.
Lewis, Gregory D.
Ho, Jennifer E.
author_sort McNeill, Jenna N.
collection PubMed
description BACKGROUND: Eicosanoids are bioactive lipids that regulate systemic inflammation and exert vasoactive effects. Specific eicosanoid metabolites have previously been associated with pulmonary hypertension (PH), yet their role remains incompletely understood. METHODS: We studied 482 participants with chronic dyspnoea who underwent clinically indicated cardiopulmonary exercise testing (CPET) with invasive haemodynamic monitoring. We performed comprehensive profiling of 888 eicosanoids and eicosanoid-related metabolites using directed non-targeted mass spectrometry, and examined associations with PH (mean pulmonary arterial pressure (mPAP) >20 mmHg), PH subtypes and physiological correlates, including transpulmonary metabolite gradients. RESULTS: Among 482 participants (mean±sd age 56±16 years, 62% women), 200 had rest PH. We found 48 eicosanoids and eicosanoid-related metabolites that were associated with PH. Specifically, prostaglandin (11β-dhk-PGF2α), linoleic acid (12,13-EpOME) and arachidonic acid derivatives (11,12-DiHETrE) were associated with higher odds of PH (false discovery rate q<0.05 for all). By contrast, epoxide (8(9)-EpETE), α-linolenic acid (13(S)-HOTrE(γ)) and lipokine derivatives (12,13-DiHOME) were associated with lower odds. Among PH-related eicosanoids, 14 showed differential transpulmonary metabolite gradients, with directionality suggesting that metabolites associated with lower odds of PH also displayed pulmonary artery uptake. In individuals with exercise PH, eicosanoid profiles were intermediate between no PH and rest PH, with six metabolites that differed between rest and exercise PH. CONCLUSIONS: Our findings highlight the role of specific eicosanoids, including linoleic acid and epoxide derivatives, as potential regulators of inflammation in PH. Of note, physiological correlates, including transpulmonary metabolite gradients, may prioritise future studies focused on eicosanoid-related pathways as important contributors to PH pathogenesis.
format Online
Article
Text
id pubmed-10586234
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-105862342023-10-20 The association of eicosanoids and eicosanoid-related metabolites with pulmonary hypertension McNeill, Jenna N. Roshandelpoor, Athar Alotaibi, Mona Choudhary, Arrush Jain, Mohit Cheng, Susan Zarbafian, Shahrooz Lau, Emily S. Lewis, Gregory D. Ho, Jennifer E. Eur Respir J Original Research Articles BACKGROUND: Eicosanoids are bioactive lipids that regulate systemic inflammation and exert vasoactive effects. Specific eicosanoid metabolites have previously been associated with pulmonary hypertension (PH), yet their role remains incompletely understood. METHODS: We studied 482 participants with chronic dyspnoea who underwent clinically indicated cardiopulmonary exercise testing (CPET) with invasive haemodynamic monitoring. We performed comprehensive profiling of 888 eicosanoids and eicosanoid-related metabolites using directed non-targeted mass spectrometry, and examined associations with PH (mean pulmonary arterial pressure (mPAP) >20 mmHg), PH subtypes and physiological correlates, including transpulmonary metabolite gradients. RESULTS: Among 482 participants (mean±sd age 56±16 years, 62% women), 200 had rest PH. We found 48 eicosanoids and eicosanoid-related metabolites that were associated with PH. Specifically, prostaglandin (11β-dhk-PGF2α), linoleic acid (12,13-EpOME) and arachidonic acid derivatives (11,12-DiHETrE) were associated with higher odds of PH (false discovery rate q<0.05 for all). By contrast, epoxide (8(9)-EpETE), α-linolenic acid (13(S)-HOTrE(γ)) and lipokine derivatives (12,13-DiHOME) were associated with lower odds. Among PH-related eicosanoids, 14 showed differential transpulmonary metabolite gradients, with directionality suggesting that metabolites associated with lower odds of PH also displayed pulmonary artery uptake. In individuals with exercise PH, eicosanoid profiles were intermediate between no PH and rest PH, with six metabolites that differed between rest and exercise PH. CONCLUSIONS: Our findings highlight the role of specific eicosanoids, including linoleic acid and epoxide derivatives, as potential regulators of inflammation in PH. Of note, physiological correlates, including transpulmonary metabolite gradients, may prioritise future studies focused on eicosanoid-related pathways as important contributors to PH pathogenesis. European Respiratory Society 2023-10-19 /pmc/articles/PMC10586234/ /pubmed/37857430 http://dx.doi.org/10.1183/13993003.00561-2023 Text en Copyright ©The authors 2023. https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org)
spellingShingle Original Research Articles
McNeill, Jenna N.
Roshandelpoor, Athar
Alotaibi, Mona
Choudhary, Arrush
Jain, Mohit
Cheng, Susan
Zarbafian, Shahrooz
Lau, Emily S.
Lewis, Gregory D.
Ho, Jennifer E.
The association of eicosanoids and eicosanoid-related metabolites with pulmonary hypertension
title The association of eicosanoids and eicosanoid-related metabolites with pulmonary hypertension
title_full The association of eicosanoids and eicosanoid-related metabolites with pulmonary hypertension
title_fullStr The association of eicosanoids and eicosanoid-related metabolites with pulmonary hypertension
title_full_unstemmed The association of eicosanoids and eicosanoid-related metabolites with pulmonary hypertension
title_short The association of eicosanoids and eicosanoid-related metabolites with pulmonary hypertension
title_sort association of eicosanoids and eicosanoid-related metabolites with pulmonary hypertension
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586234/
https://www.ncbi.nlm.nih.gov/pubmed/37857430
http://dx.doi.org/10.1183/13993003.00561-2023
work_keys_str_mv AT mcneilljennan theassociationofeicosanoidsandeicosanoidrelatedmetaboliteswithpulmonaryhypertension
AT roshandelpoorathar theassociationofeicosanoidsandeicosanoidrelatedmetaboliteswithpulmonaryhypertension
AT alotaibimona theassociationofeicosanoidsandeicosanoidrelatedmetaboliteswithpulmonaryhypertension
AT choudharyarrush theassociationofeicosanoidsandeicosanoidrelatedmetaboliteswithpulmonaryhypertension
AT jainmohit theassociationofeicosanoidsandeicosanoidrelatedmetaboliteswithpulmonaryhypertension
AT chengsusan theassociationofeicosanoidsandeicosanoidrelatedmetaboliteswithpulmonaryhypertension
AT zarbafianshahrooz theassociationofeicosanoidsandeicosanoidrelatedmetaboliteswithpulmonaryhypertension
AT lauemilys theassociationofeicosanoidsandeicosanoidrelatedmetaboliteswithpulmonaryhypertension
AT lewisgregoryd theassociationofeicosanoidsandeicosanoidrelatedmetaboliteswithpulmonaryhypertension
AT hojennifere theassociationofeicosanoidsandeicosanoidrelatedmetaboliteswithpulmonaryhypertension
AT mcneilljennan associationofeicosanoidsandeicosanoidrelatedmetaboliteswithpulmonaryhypertension
AT roshandelpoorathar associationofeicosanoidsandeicosanoidrelatedmetaboliteswithpulmonaryhypertension
AT alotaibimona associationofeicosanoidsandeicosanoidrelatedmetaboliteswithpulmonaryhypertension
AT choudharyarrush associationofeicosanoidsandeicosanoidrelatedmetaboliteswithpulmonaryhypertension
AT jainmohit associationofeicosanoidsandeicosanoidrelatedmetaboliteswithpulmonaryhypertension
AT chengsusan associationofeicosanoidsandeicosanoidrelatedmetaboliteswithpulmonaryhypertension
AT zarbafianshahrooz associationofeicosanoidsandeicosanoidrelatedmetaboliteswithpulmonaryhypertension
AT lauemilys associationofeicosanoidsandeicosanoidrelatedmetaboliteswithpulmonaryhypertension
AT lewisgregoryd associationofeicosanoidsandeicosanoidrelatedmetaboliteswithpulmonaryhypertension
AT hojennifere associationofeicosanoidsandeicosanoidrelatedmetaboliteswithpulmonaryhypertension